Serum leptin and adiponectin are positively associated with bone mineral density at the distal radius in patients with type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 56, Issue 5, 2007, Pages 623-628

  Tamura, Tomoko ^a   Yoneda, Masayasu ^a   Yamane, Kiminori ^a   Nakanishi, Shuhei ^a   Nakashima, Reiko ^a   Okubo, Masamichi ^a   Kohno, Nobuoki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; AMINO TERMINAL TELOPEPTIDE; LEPTIN; OSTEOCALCIN;

ADULT; AGED; ARTICLE; BONE DENSITY; CLINICAL ARTICLE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HUMAN; JAPANESE; LUMBAR SPINE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIUS;

ADIPONECTIN; BODY MASS INDEX; BONE DENSITY; COLLAGEN TYPE I; DENSITOMETRY, X-RAY; DIABETES MELLITUS, TYPE 2; FEMALE; FEMUR NECK; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LEPTIN; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOCALCIN; PEPTIDES; RADIUS; REGRESSION ANALYSIS;

EID: 34147184714     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.12.008     Document Type: Article

References (50)

1. Vestergaard P., Rejnmark L., and Mosekilde L. Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia 48 (2005) 1292-1299
2. de Liefde II A.V., van der Klift M., de Laet C.E., et al. Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int 16 (2005) 1713-1720
3. Schwartz A.V., Sellmeyer D.E., Strotmeyer E.S., et al. Diabetes and bone loss at the hip in older black and white adults. J Bone Miner Res 20 (2005) 596-603
4. Strotmeyer E.S., Cauley J.A., Schwartz A.V., et al. Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Arch Intern Med 165 (2005) 1612-1617
5. Schwartz A.V. Diabetes mellitus: does it affect bone?. Calcif Tissue Int 73 (2003) 515-519
6. Kennedy R.L., Henry J., Chapman A.J., et al. Accidents in patients with insulin-treated diabetes: increased risk of low-impact falls but not motor vehicle crashes-a prospective register-based study. J Trauma 52 (2002) 660-666
7. Seino Y., and Ishida H. Diabetic osteopenia-pathophysiology and clinical aspect. Diabetes Metab Rev 11 (1995) 21-35
8. Tuominen J.T., Puukka P., Impivaara O., et al. Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 22 (1999) 1196-1200
9. Ishida H., Seino Y., Matsukura S., et al. Diabetic osteopenia and circulating levels of vitamin D metabolites in type 2 (non-insulin dependent) diabetes. Metabolism 34 (1985) 797-801
10. Isaia G., Bodrato L., Carlevatto V., et al. Osteoporosis in type II diabetes. Acta Diabetol Lat 24 (1987) 305-310
11. Gregorio F., Cristallini S., Santeusanio F., et al. Osteopenia associated with non-insulin-dependent diabetes mellitus: what are the causes?. Diabetes Res Clin Pract 23 (1994) 43-54
12. Wakasugi M., Wakao R., Tawata M., et al. Bone mineral density by dual energy x-ray absorptiometry in patients with non-insulin-dependent diabetes mellitus. Bone 14 (1993) 29-33
13. Sosa M., Dominguez M., Navarro M.C., et al. Bone mineral metabolism is normal in non-insulin-dependent diabetes mellitus. J Diabetes Complications 10 (1996) 201-205
14. Barrett-Connor E., and Holbrook T.L. Sex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitus. JAMA 16 (1992) 3333-3337
15. Van Daele P.L., Stolk R.P., Burger H., et al. Bone density in non-insulin-dependent diabetes mellitus: the Rotterdam Study. Ann Intern Med 122 (1995) 409-414
16. Isaia G.C., Ardissone P., Di Stefano M., et al. Bone metabolism in type 2 diabetes mellitus. Acta Diabetol 36 (1999) 35-38
17. Considine R.V., Sinha M.K., Heiman M.L., et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334 (1996) 292-295
18. Hotta K., Funahashi T., Arita Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20 (2000) 1595-1599
19. Ouchi N., Kihara S., Arita Y., et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100 (1999) 2473-2476
20. Felson D.T., Zhang Y., Hannan M.T., et al. Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res 8 (1993) 567-573
21. Liu J.M., Zhao H.Y., Ning G., et al. Relationship between body composition and bone mineral density in healthy young and premenopausal Chinese women. Osteoporos Int 15 (2004) 238-242
22. Lei S.F., Deng F.Y., Li M.X., et al. Bone mineral density in elderly Chinese: effects of age, sex, weight, height, and body mass index. J Bone Miner Metab 22 (2004) 71-78
23. Cvijetic S., and Korsic M. Apparent bone mineral density estimated from DXA in healthy men and women. Osteoporos Int 5 (2004) 295-300
24. Brooks E.R., Heltz D., Wozniak P., et al. Lateral spine densitometry in obese women. Calcif Tissue Int 63 (1998) 173-176
25. Takata S., Ikata T., and Yonezu H. Characteristics of bone mineral density and soft tissue composition of obese Japanese women: application of dual-energy X-ray absorptiometry. J Bone Miner Metab 17 (1999) 206-210
26. Yamauchi M., Sugimoto T., Yamaguchi T., et al. Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women. Clin Endocrinol 55 (2001) 341-347
27. Sato M., Takeda N., Sarui H., et al. Association between serum leptin concentrations and bone mineral density, and biochemical markers of bone turnover in adult men. J Clin Endocrinol Metab 86 (2001) 5273-5276
28. Morberg C.M., Tetens I., Black E., et al. Leptin and bone mineral density: a cross-sectional study in obese and nonobese men. J Clin Endocrinol Metab 88 (2003) 5795-5800
29. Kontogianni M.D., Dafni U.G., Routsias J.G., et al. Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. J Bone Miner Res 19 (2004) 546-551
30. Huang K.C., Cheng W.C., Yen R.F., et al. Lack of independent relationship between plasma adiponectin, leptin levels and bone density in nondiabetic female adolescents. Clin Endocrinol 61 (2004) 204-208
31. Ruhl C.E., and Everhart J.E. Relationship of serum leptin concentration with bone mineral density in the United States population. J Bone Miner Res 17 (2002) 1896-1903
32. Ducy P., Amling M., Takeda S., et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100 (2000) 197-207
33. Takeda S., Elefteriou F., Levasseur R., et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 111 (2002) 305-317
34. Steppan C.M., Crawford D.T., Chidsey-Frink K.L., et al. Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Pept 92 (2000) 73-78
35. Reseland J.E., Syversen U., Bakke I., et al. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res 16 (2001) 1426-1433
36. Iwamoto I., Fujino T., and Douchi T. The leptin receptor in human osteoblasts and the direct effect of leptin on bone metabolism. Gynecol Endocrinol 19 (2004) 97-104
37. Thomas T., Gori F., Khosla S., et al. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140 (1999) 1630-1638
38. Lenchik L., Register T.C., Hsu F.C., et al. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 33 (2003) 646-651
39. Majima T., Komatsu Y., Yamada T., et al. Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patients. Osteoporos Int 19 (2004) 907-913
40. Akin O., Göl K., Aktürk M., et al. Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements. Gynecol Endocrinol 17 (2003) 19-29
41. Horiuchi T., Kazama H., Araki A., et al. Impaired gamma carboxylation of osteocalcin in elderly women with type II diabetes mellitus: relationship between increase in undercarboxylated osteocalcin levels and low bone mineral density. J Bone Miner Metab 22 (2004) 236-240
42. Goulding A., and Taylor R.W. Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women. Calcif Tissue Int 63 (1998) 456-458
43. Ogueh O., Sooranna S., Nicolaides K.H., et al. The relationship between leptin concentration and bone metabolism in the human fetus. J Clin Endocrinol Metab 85 (2000) 1997-1999
44. Holloway W.R., Collier F.M., Aitken C.J., et al. Leptin inhibits osteoclast generation. J Bone Miner Res 17 (2002) 200-209
45. Bouillon R., Bex M., Van Herck E., et al. Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus. J Clin Endocrinol Metab 80 (1995) 1194-1202
46. Okazaki R., Totsuka Y., Hamano K., et al. Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover. J Clin Endocrinol Metab 82 (1997) 2915-2920
47. Hatzigeorgiou C., and Jackson J.L. Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis. Osteoporos Int 16 (2005) 990-998
48. Staal A., Frith J.C., French M.H., et al. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity. J Bone Miner Res 18 (2003) 88-96
49. Berner H.S., Lyngstadaas S.P., Spahr A., et al. Adiponectin and its receptors are expressed in bone-forming cells. Bone 35 (2004) 842-849
50. Oshima K., Nampei A., Matsuda M., et al. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun 331 (2005) 520-526